SSII earnings: next report 2026-08-10, real EPS beat/miss history, P/E -67.29. Updated 2026-07-23.
SS Innovations International (SSII) Research Hub
SS Innovations International (SSII) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 3.31 USD (+2.80%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -67.29, market cap 0.72B. This hub links to the full technical, earnings and options research available for SSII.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.31 USD (+2.80%) |
| 52-week range | 3.22 USD – 4.2 USD |
| Trend regime | Range |
| 14-day RSI | 31.7 (Bearish) |
| Trailing P/E | -67.29 |
| Market cap | 0.72B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-10 |
Available research for SSII
Covered Call on SSII: how it works, illustrative setup around the real 3.31 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SSII: how it works, illustrative setup around the real 3.31 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SSII: how it works, illustrative setup around the real 3.31 USD price, max profit/loss, breakeven and when to use it. Educational.
SSII technical analysis: range, last 3.31 USD, RSI 31.7, 52w range 3.22 USD–4.2 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is SSII in?
SS Innovations International (SSII) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is SSII in an uptrend or downtrend?
As of 2026-09-11, SSII is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SSII's trailing P/E ratio?
SSII's trailing P/E is -67.29, with a market cap of 0.72B. See the earnings research page for full valuation detail.
When does SSII next report earnings?
SSII is next scheduled to report earnings on 2026-08-10, with a consensus EPS estimate of -0.01 USD.